News

The new MCI ® brochure brings together four corrosion-fighting product categories into one place, creating a convenient ...
The Delacorte, renovated for $85 million, welcomes back audiences for Shakespeare in the Park. It echoes the park’s ethos, ...
Fresenius Kabi has licensed rights from Polpharma Biologics to commercialize the vedolizumab biosimilar candidate PB016 globally—except in the ...